InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,576.98
(
0.07%
)
US TECH 100
19,930.80
(
0.19%
)
Dow Jones
39,291.97
(
-0.13%
)
Brent Oil
84.54
(
-0.18%
)
Bitcoin
57,886.35
(
-0.23%
)
Post# of 252539
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 831
Posts 120006
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 199020

Thursday, 10/27/2016 12:43:38 PM

Thursday, October 27, 2016 12:43:38 PM

Post# of 252539
Re: ADXS 2016 news flow

Based on today’s AZN news (#msg-126101997), the fifth bullet item in #msg-119786171 may be delayed beyond the end of 2016:

Complete enrollment in the combination Phase 1/2 study with [AZN’s] durvalumab for the treatment of HPV-associated head and neck and cervical cancer in late 2016.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up